Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel 5-HT7 antagonists for CNS disorders under investigation at DuPont

Feb. 3, 2000

Boston Life Sciences identifies target of CNS growth factor products

Feb. 3, 2000

Idun and Elan establish stroke therapy collaboration

Feb. 3, 2000

Cambridge Drug Discovery and Parke-Davis complete screening collaboration

Feb. 3, 2000

Arena and Fujisawa establish collaboration in neurodegenerative disease area

Feb. 3, 2000

Patient enrollment completed in phase II trial of memantine for AIDS-related dementia

Feb. 2, 2000

Brief application of PEG reverses damage from spinal cord injury in guinea pigs

Feb. 2, 2000

Promising Sepracor compound with triple mechanism of action enters clinical testing

Feb. 2, 2000

Ono discloses N-type calcium channel blockers and their use

Feb. 1, 2000

Roche devotes resources to study of orphan opioid receptor ligands

Feb. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.